BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Upstate Sponsors First Annual Cell Signalling Symposium June 6-9, 2004


10/19/2005 5:10:59 PM

CHARLOTTESVILLE, Va., April 21 /PRNewswire/ -- The First Annual Cell Signalling Symposium will be held June 6-9, 2004, at the West Park Centre, Dundee, U.K. It is co-sponsored by Upstate and the MRC Protein Phosphorylation Unit at the University of Dundee. This two-and-a-half day, not-for-profit meeting is entitled 'Regulation and Therapeutic Potential of the PI 3-Kinase/PKB Signalling Pathway.' Registration is open to all scientists with an interest in cell signalling, drug discovery and disease.

The keynote lecture will be held on Sunday evening, June 6, by Stephen O'Rahilly from Cambridge, UK, on the Identification of Novel Genes that Predispose to Diabetes and Obesity. Other featured speakers include Sir Philip Cohen, Dario Alessi, Morris White, Laurence Pearl, Peter Downes, plus many other well-known scientists. Topics featured will include: The Role of PKB in Cell Transformation and Cancer; Development and Therapeutic Potential of PI 3-Kinase Inhibitors; Insulin/IGF-1 Signalling and Lifespan; Serine Phosphorylation of IRS Proteins and Insulin Resistance; Development and Therapeutic Potential of PTP Inhibitors; and others for a total of 23 sessions.

Also at the symposium, the winner of the Upstate Young Cell Signaller 2004 Award will be announced from five finalists chosen from Ph.D. students and first time post-doctorates who submitted abstracts to an experienced scientific panel for judging. The winner will receive $17,000 worth of support funding for reagents for their laboratory, a personal cash prize of $8,500 and a trophy.

To find out more about the symposium or to register, visit http://www.upstate.com/symposium, call Michelle Hynd at +44 (0) 1908 552839 or e-mail registration@upstate.com.

Upstate is the leading supplier of innovative cell signaling products, technology, platforms and services. Founded in 1988, Upstate provides researchers at pharmaceutical and biotechnology companies, universities and government agencies with advanced tools to accelerate life science research and drug discovery. Upstate's global reach includes six locations in the U.S. and Europe with key technology centers in its Charlottesville, VA headquarters; Lake Placid, NY; and Dundee and Cambridge in the U.K.

Upstate

CONTACT: Reese A. Nank, APR, of Reputations PR and Marketing,+1-410-218-9121, or reputationspr@cox.net, for Upstate


Read at BioSpace.com


Upstate
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->